Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals - The Lancet
Could a single-dose vaccine strategy be more beneficial in COVID-19?
First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales | PLOS Medicine
Will a first-dose vaccine strategy help beat the variants? | MIT Technology Review
Those Who Had COVID-19 May Only Need One Dose of Vaccine | Penn Medicine
Why you need the second COVID-19 vaccine dose | OSF HealthCare
PM Narendra Modi gets Covid jab as India scales up vaccination - BBC News
Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures | NEJM
Pfizer's Vaccine Offers Strong Protection After First Dose - The New York Times
Israeli study finds Pfizer vaccine 85% effective after first shot | Reuters
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Pfizer vaccine may offer strong protection after first dose, Israeli study finds
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet
Frontiers | Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy
I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate
Op-Ed: Forget Second COVID Vaccine Doses for Now | MedPage Today
Who Didn't Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines | KFF
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
First Covid vaccine dose: What can you do after your first shot?
First dose of Pfizer-BioNTech or Oxford-AstraZeneca vaccines has strong protective effect against COVID-19 in older adults
Is One Vaccine Dose Enough After COVID-19 Infection? – NIH Director's Blog
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 | Nature
